Larimar Therapeutics, Inc. (LRMR)
Across 21 earnings reports since May 10, 2021, Larimar Therapeutics, Inc. (LRMR) has a clear post-earnings pattern. It moves ±8.91% on average after reporting and finishes higher 47.6% of the time. Its largest post-earnings gain was +14.52% (Aug 14, 2025) and its largest decline was -36.28% (May 10, 2021). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings reactions
How LRMR moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±8.91%
Positive %
47.6%
Negative %
52.4%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 14, 2026 | ☀ PRE | -5.12% | open_in_new |
| Mar 19, 2026 | ☀ PRE | +3.95% | open_in_new |
| Nov 05, 2025 | ☀ PRE | -15.26% | open_in_new |
| Aug 14, 2025 | ☀ PRE | +14.52% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±8.91%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260708 | open_in_new SEC.gov |
| 8-K | 20260629 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 8-K | 20260519 | open_in_new SEC.gov |
| 10-Q | 20260514 | open_in_new SEC.gov |
Frequently asked about LRMR earnings
When does Larimar Therapeutics, Inc. report earnings next? expand_more
Larimar Therapeutics, Inc. (LRMR)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LRMR stock move after earnings? expand_more
Over 21 reports, LRMR has moved an average of ±8.91% the session after earnings, closing higher 47.6% of the time.
What was LRMR's biggest post-earnings move? expand_more
LRMR's largest post-earnings gain on record was +14.52% on Aug 14, 2025, and its largest decline was -36.28% on May 10, 2021.
Where can I find Larimar Therapeutics, Inc.'s SEC filings? expand_more
All of Larimar Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALICO, INC. (ALCO) earnings 2026-08-07
- ASCENT INDUSTRIES CO. (ACNT) earnings 2026-08-07
- Aclaris Therapeutics, Inc. (ACRS) earnings 2026-08-07
- ACV Auctions Inc. (ACVA) earnings 2026-08-07
- ADC Therapeutics SA (ADCT) earnings 2026-08-07
- ADMA BIOLOGICS, INC. (ADMA) earnings 2026-08-07
- Aeva Technologies, Inc. (AEVA) earnings 2026-08-07
- Agenus Inc. Common Stock (AGEN) earnings 2026-08-07